HT
EW icon

HAP Trading’s Edwards Lifesciences EW Stock Holding History

HAP Trading’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-133,386
Closed -$8.51M – 1187
2019
Q1 		$8.51M Buy
+133,386
New +$7.61M 0.76% 34
2018
Q2 		– Sell
-51,777
Closed -$2.41M – 1013
2018
Q1 		$2.41M Buy
+51,777
New +$2.25M 0.12% 124
2016
Q4 		– Sell
-96,015
Closed -$3.86M – 1055
2016
Q3 		$3.86M Buy
+96,015
New +$3.62M 0.14% 92
2013
Q4 		– Sell
-156,684
Closed -$1.77M – 1253
2013
Q3 		$1.82M Buy
+156,684
New +$1.83M 0.06% 245

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

HAP Trading's EW Position: Q2 2019 in Review

HAP Trading sold out of Edwards Lifesciences (EW) in Q2 2019, closing a stake of 133,386 shares — an estimated $8.51M sold.

HAP Trading first reported a position in EW in Q3 2013 and held it in 4 quarters. The position peaked at $8.51M in Q1 2019. 921 funds tracked by Wall St. Rank hold EW as of Q2 2019.

  • HAP Trading reported no remaining Edwards Lifesciences position as of Q2 2019 after selling out during the quarter.
  • HAP Trading sold 133,386 Edwards Lifesciences shares in Q2 2019, an estimated $8.51M.
  • HAP Trading first reported a position in Edwards Lifesciences in Q3 2013 and held it in 4 quarters.
  • HAP Trading's Edwards Lifesciences position peaked at $8.51M in Q1 2019.
  • 921 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2019.

Based on HAP Trading's 13F filing for Q2 2019, filed 14 Aug 2019.